Improving blood flow recovery after stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a new approach to restore blood flow in the brain after a stroke. It aims to improve recovery and brain function in people with a blocked large artery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 90 years old.
- You had a stroke caused by a blocked major artery in the brain (like the internal carotid or middle cerebral artery).
- Brain scans show there is still some brain tissue that can be saved.
- Your stroke symptoms are moderate to severe (NIHSS score of 5 or higher).
- You do not have a large area of dead brain tissue, bleeding in the brain, or other serious conditions that would make the treatment unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, J147, for people who recently had a stroke caused by a blocked artery and have already had a procedure to reopen that artery. It aims to see if the drug can improve recovery.
This trial tests a simple procedure that may help your brain recover after a stroke. The procedure involves briefly stopping and restarting blood flow in your arm, which may reduce brain damage and improve recovery after the clot removal.
This trial tests whether giving a clot-busting drug called tenecteplase directly into the blocked blood vessel in the brain can help people with a medium-sized vessel occlusion stroke. The drug may help restore blood flow and reduce disability, and it is given within 24 hours of symptom onset.
This study enrolls people who had an acute ischemic stroke (caused by a blood clot) and received emergency treatment to remove the clot. Researchers want to understand why some patients recover well while others don't, by measuring how the brain regulates its own blood flow after treatment.
This trial tests a new clot-busting medicine called tenecteplase, given directly into the blood vessel in the brain, to treat strokes caused by a blockage in a medium-sized artery. The goal is to see if it can help restore blood flow and reduce disability, especially for patients who can be treated within 24 hours of stroke onset.
This study tests a simple, non-invasive treatment called remote ischemic preconditioning. It uses a blood pressure cuff on your arm to temporarily restrict blood flow, which may help improve blood flow to the brain after a stroke. The goal is to see if this can strengthen the brain's backup blood vessels and aid recovery.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.